These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7209869)

  • 1. An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man.
    Meyers KM; Katz JB; Clemmons RM; Smith JB; Holmsen H
    Thromb Res; 1980 Oct; 20(1):13-24. PubMed ID: 7209869
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma.
    Stockschläder M; Scharf RE
    Thromb Haemost; 1989 Nov; 62(3):1016-22. PubMed ID: 2512674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin.
    Reimers HJ; Baker RK; Joist JH
    Thromb Res; 1987 Dec; 48(5):535-48. PubMed ID: 3126557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
    Nosál' R; Jancinová V; Petríková M
    Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders.
    Russell NH; Salmon J; Keenan JP; Bellingham AJ
    Thromb Res; 1981 May; 22(4):389-97. PubMed ID: 6794179
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate.
    Wachowicz B
    Cytobios; 1993; 75(302-303):157-62. PubMed ID: 8243105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid.
    Lagarde M; Vericel E; Guichardant M; Dechavanne M
    Biochem Biophys Res Commun; 1981 Apr; 99(4):1398-402. PubMed ID: 7259783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.